US Patent 9783825 Recombinant adeno-associated vectors for targeted treatment
Patent 9783825 was granted and assigned to City of Hope on October, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9783825 Recombinant adeno-associated vectors for targeted treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
